Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a seminal manuscript in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback